FOCIS 2016, Boston

This week, during FOCIS 2016, Amrie Grammer, PhD will give a presentation on the identification of novel drug targets for repositioning in Lupus, in addition to Ampel having two posters at the conference. For more information on FOCIS 2016 visit

Pilot study with UVa to explore more ways to tackle lupus

“A pilot study at UVa Research Park will explore the science behind the old saying “mind over matter.”

A local company called AMPEL Biosolutions is teaming up with the University of Virginia to examine the effects of contemplative practices — such as meditation — on lupus patients.

The idea of combining contemplative practices with modern medicine isn’t new. Doctors know reducing emotional stress promotes general wellbeing and aids in physical recovery. But the collaborative study between AMPEL and UVa’s Contemplative Sciences Center will examine the physiological effects of such practices — which could have far-reaching implications for the medical field. …

The drought has AMPEL Biosolutions, which specializes in lupus research, looking for answers in many different places. The firm is also behind a massive drug repositioning project — that is, a study of how existing drugs (used to treat other conditions) could be useful for treating lupus.

The company is trying a more conventional approach, as well, searching for useful targets in the body that could, down the road, be exploited by a drug.

The multi-pronged approach is necessary because lupus affects so many parts of the body, manifests in a wide variety of symptoms and is affected by many different genes, said Dr. Amrie Grammer, scientific director at AMPEL Biosolutions.” …

Pilot study with UVa to explore more ways to tackle lupus
– by DEREK QUIZON (Published in the Daily Progress)

Full article:


The American Association of Immunologist is hosting their annual meeting in Seattle this week, May 13-17, 2016, and AMPEL BioSolutions is there! This year AMPEL is presenting their poster entitled Meta-Analysis from Gene Expression Profiles of Lupus Affected Tissues Reveals Novel Immune Cell Contributions. For more information on IMMUNOLOGY 2016 visit